199 related articles for article (PubMed ID: 35269542)
21. Heparin remodels the microtubule-binding repeat R3 of Tau protein towards fibril-prone conformations.
Dong X; Qi R; Qiao Q; Li X; Li F; Wan J; Zhang Q; Wei G
Phys Chem Chem Phys; 2021 Sep; 23(36):20406-20418. PubMed ID: 34494046
[TBL] [Abstract][Full Text] [Related]
22. The Lys 280 → Gln mutation mimicking disease-linked acetylation of Lys 280 in tau extends the structural core of fibrils and modulates their catalytic properties.
Kumar H; Udgaonkar JB
Protein Sci; 2021 Apr; 30(4):785-803. PubMed ID: 33496017
[TBL] [Abstract][Full Text] [Related]
23. In Silico Evaluation of Acetylation Mimics in the 27 Lysine Residues of Human Tau Protein.
Kim YC; Jeong BH
Curr Alzheimer Res; 2019; 16(5):379-387. PubMed ID: 30907318
[TBL] [Abstract][Full Text] [Related]
24. N-glycosylation induced changes in tau protein dynamics reveal its role in tau misfolding and aggregation: A microsecond long molecular dynamics study.
Mathew AT; Baidya ATK; Das B; Devi B; Kumar R
Proteins; 2023 Feb; 91(2):147-160. PubMed ID: 36029032
[TBL] [Abstract][Full Text] [Related]
25. Increased acetylation of microtubules rescues human tau-induced microtubule defects and neuromuscular junction abnormalities in
Mao CX; Wen X; Jin S; Zhang YQ
Dis Model Mech; 2017 Oct; 10(10):1245-1252. PubMed ID: 28819043
[TBL] [Abstract][Full Text] [Related]
26. Cellular factors modulating the mechanism of tau protein aggregation.
Fontaine SN; Sabbagh JJ; Baker J; Martinez-Licha CR; Darling A; Dickey CA
Cell Mol Life Sci; 2015 May; 72(10):1863-79. PubMed ID: 25666877
[TBL] [Abstract][Full Text] [Related]
27. Deciphering the Inhibitory Mechanism of Naphthoquinone-Dopamine on the Aggregation of Tau Core Fragments PHF6* and PHF6.
Zou Y; Qi B; Tan J; Guan L; Zhang Q; Sun Y; Huang F
ACS Chem Neurosci; 2023 Sep; 14(17):3265-3277. PubMed ID: 37585669
[TBL] [Abstract][Full Text] [Related]
28. A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation.
Ajit D; Trzeciakiewicz H; Tseng JH; Wander CM; Chen Y; Ajit A; King DP; Cohen TJ
J Biol Chem; 2019 Nov; 294(45):16698-16711. PubMed ID: 31543505
[TBL] [Abstract][Full Text] [Related]
29. A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy.
Trzeciakiewicz H; Tseng JH; Wander CM; Madden V; Tripathy A; Yuan CX; Cohen TJ
Sci Rep; 2017 Mar; 7():44102. PubMed ID: 28287136
[TBL] [Abstract][Full Text] [Related]
30. Atomistic mechanism of polyphenol amyloid aggregation inhibitors: molecular dynamics study of Curcumin, Exifone, and Myricetin interaction with the segment of tau peptide oligomer.
Berhanu WM; Masunov AE
J Biomol Struct Dyn; 2015; 33(7):1399-411. PubMed ID: 25093402
[TBL] [Abstract][Full Text] [Related]
31. The acetylation of tau inhibits its function and promotes pathological tau aggregation.
Cohen TJ; Guo JL; Hurtado DE; Kwong LK; Mills IP; Trojanowski JQ; Lee VM
Nat Commun; 2011; 2():252. PubMed ID: 21427723
[TBL] [Abstract][Full Text] [Related]
32. Atomic insights into the inhibition of R3 domain of tau protein by epigallocatechin gallate, quercetin and gallic acid.
Tang J; Sun R; Wan J; Xu Z; Zou Y; Zhang Q
Biophys Chem; 2024 Feb; 305():107142. PubMed ID: 38088006
[TBL] [Abstract][Full Text] [Related]
33. Protein folding, misfolding and aggregation: The importance of two-electron stabilizing interactions.
Cieplak AS
PLoS One; 2017; 12(9):e0180905. PubMed ID: 28922400
[TBL] [Abstract][Full Text] [Related]
34. Copper (Cu
Jing J; Tu G; Yu H; Huang R; Ming X; Zhan H; Zhan F; Xue W
Phys Chem Chem Phys; 2021 May; 23(20):11717-11726. PubMed ID: 33982037
[TBL] [Abstract][Full Text] [Related]
35. Inhibitive and Destructive Mechanisms of Chronic Traumatic Encephalopathy-Related R3-R4 Tau Peptide Chains and Protofibril by Epigallocatechin Gallate: Evidence from Molecular Dynamics Simulation.
Tang J; Sun R; Wan J; Xu Z; Gong Y; Zou Y; Zhang Q
ACS Chem Neurosci; 2023 Jun; 14(11):2098-2111. PubMed ID: 37213134
[TBL] [Abstract][Full Text] [Related]
36. Polyphosphate Initiates Tau Aggregation through Intra- and Intermolecular Scaffolding.
Wickramasinghe SP; Lempart J; Merens HE; Murphy J; Huettemann P; Jakob U; Rhoades E
Biophys J; 2019 Aug; 117(4):717-728. PubMed ID: 31400913
[TBL] [Abstract][Full Text] [Related]
37. Can any "non-specific charge modification within microtubule binding domains of Tau" be a prerequisite of the protein amyloid aggregation? An in vitro study on the 1N4R isoform.
Jangholi A; Ashrafi-Kooshk MR; Arab SS; Karima S; Poorebrahim M; Ghadami SA; Moosavi-Movahedi AA; Khodarahmi R
Int J Biol Macromol; 2018 Apr; 109():188-204. PubMed ID: 29248553
[TBL] [Abstract][Full Text] [Related]
38. Initiation of assembly of tau(273-284) and its ΔK280 mutant: an experimental and computational study.
Larini L; Gessel MM; LaPointe NE; Do TD; Bowers MT; Feinstein SC; Shea JE
Phys Chem Chem Phys; 2013 Jun; 15(23):8916-28. PubMed ID: 23515417
[TBL] [Abstract][Full Text] [Related]
39. Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation.
Grinberg LT; Wang X; Wang C; Sohn PD; Theofilas P; Sidhu M; Arevalo JB; Heinsen H; Huang EJ; Rosen H; Miller BL; Gan L; Seeley WW
Acta Neuropathol; 2013 Apr; 125(4):581-93. PubMed ID: 23371364
[TBL] [Abstract][Full Text] [Related]
40. Understanding molecular features of aggregation-resistant tau conformer using oxidized monomer.
Jebarupa B; Mathew B; Srinivasu BY; Sasikumaran A; Joseph S; Mandal AK; Thomas T; Mitra G
Biochim Biophys Acta Gen Subj; 2019 Jun; 1863(6):993-1005. PubMed ID: 30853336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
